Lido Advisors
RVMD icon

Lido Advisors’s Revolution Medicines RVMD Stock Holding History

Lido Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.69M Sell
8,217
-259
-3% -$51.3K ﹤0.01% 862
2026
Q2 		$1.59M Buy
8,476
+5,858
+224% +$856K ﹤0.01% 886
2026
Q1 		$255K Buy
+2,618
New +$264K ﹤0.01% 1654

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Lido Advisors's RVMD Position: Q3 2026 in Review

Lido Advisors reduced its Revolution Medicines (RVMD) stake by 3.1% in Q3 2026, selling an estimated $51.3K and leaving 8,217 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #862.

Lido Advisors first reported a position in RVMD in Q1 2026 and has held it in 3 quarters since. 490 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Lido Advisors held 8,217 shares of Revolution Medicines worth $1.69M as of Q3 2026.
  • Lido Advisors sold 259 Revolution Medicines shares in Q3 2026, an estimated $51.3K.
  • Revolution Medicines made up ﹤0.01% of Lido Advisors's portfolio in Q3 2026, its #862 holding.
  • Lido Advisors first reported a position in Revolution Medicines in Q1 2026 and has held it in 3 quarters since.
  • 490 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Lido Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.